BCBN Feed: Ongoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety Profile https://lnkd.in/gpaiquaa LEXINGTON, Mass.--(BUSINESS WIRE)--Cyteir Therapeutics, Inc. (“Cyteir”) (Nasdaq: CYT) today presented ongoing results from a dose expansion cohort in its Phase 1 combination study of CYT-0851 with capecitabine in patients with platinum-refractory or -resistant ovarian cancer in a late-breaker poster titled “Phase 1 Dose Expansion Results of CYT-0851, a Monocarboxylate Transporter... ... [...]
Boston Cambridge Biotech Networks’ Post
More Relevant Posts
-
BCBN Feed: Teva to pay $450M to settle allegations of kickbacks and generic drug price-fixing https://lnkd.in/gAVVRt9F Generics giant Teva Pharmaceuticals will pay $450 million over six years to settle two allegations that the company violated the Anti-Kickback Statute and the False Claims Act, the Department of Justice announced Thursday. The payout will resolve two matters, one of which the government filed in... ... [...]
Teva to pay $450M to settle allegations of kickbacks and generic drug price-fixing
-
BCBN Feed: Validation Institute, Healthcare Innovation Company Announce Policy Update Event for White House Strategy on Hunger, Nutrition, and Health, Oct 28, in Washington, DC https://lnkd.in/gUSe-dQK Federal agencies will discuss actions taken across the United States Government, next steps, and actionable strategies to advance the affordability, accessibility, and scalability of food and nutrition programs NEEDHAM, Mass., Oct. 10, 2024 /PRNewswire-PRWeb/ -- Validation Institute, its... ... [...]
Validation Institute, Healthcare Innovation Company Announce Policy Update Event for White House Strategy on Hunger, Nutrition, and Health, Oct 28, in Washington, DC
-
BCBN Feed: Private equity behind Stewardship buy raises concerns at HPC https://lnkd.in/gBmbq8am The state's health board is advocating for more authority to control private equity groups involved in healthcare. ... [...]
Private equity behind Stewardship buy raises concerns at HPC
-
BCBN Feed: Shares of two Mass. biotechs rise after IPOs https://lnkd.in/gmeYSc3Y Camp4 and Upstream are so far faring better than most of the other Massachusetts biotechs to IPO so far in 2024. ... [...]
Shares of two Mass. biotechs rise after IPOs
-
BCBN Feed: Bay State Banner: Life science trade group’s five-year vision includes further support for a diversified workforce https://lnkd.in/ge9-FrTu The following are excerpts from an article that originally appeared in the Bay State Banner on October 10, 2024: A new five-year plan released by the Massachusetts Biotechnology Council, or MassBio, Oct. 2, puts efforts expanding and diversifying the workforce on the list of main priorities to guide the statewide life sciences... ... [...]
Bay State Banner: Life science trade group’s five-year vision includes further support for a diversified workforce
-
BCBN Feed: Biotech startups Upstream, CAMP4 price Friday IPOs https://lnkd.in/gc9j3Nik Boston-area biotechs Upstream Bio and CAMP4 Therapeutics are headed to the Nasdaq on Friday, the latest companies to IPO in what appears to be a recovery for startups trying to raise capital on the public market. Upstream Bio priced at $17 per share, the high end of the $15 to... ... [...]
Biotech startups Upstream, CAMP4 price Friday IPOs
-
BCBN Feed: Lilly follows the trend of new AI hires; Pfizer fills key UK position as activist hubbub swells https://lnkd.in/gJ28R2AX Thomas Fuchs → Eli Lilly has joined the club of pharma companies that have lined up AI execs. Thomas Fuchs will be Lilly’s first-ever chief AI officer on Oct. 21 and comes from the Icahn School of Medicine at Mount Sinai, where he was the... ... [...]
Lilly follows the trend of new AI hires; Pfizer fills key UK position as activist hubbub swells
-
BCBN Feed: Tiny magnetic discs offer remote brain stimulation without transgenes https://lnkd.in/gVYRsjfX The devices could be a useful tool for biomedical research, and possible clinical use in the future. ... [...]
Tiny magnetic discs offer remote brain stimulation without transgenes
-
BCBN Feed: Vision 2030 Early-Stage Catalyst: Fueling Innovation in Massachusetts Biotech https://lnkd.in/gxgYayNS Imagine a small group of passionate scientists gathered in a cramped lab, where beakers bubble with the promise of groundbreaking treatments. This is how many biotech companies begin, driven by an idea that could change the world. However, the journey from concept to commercialization is fraught with challenges. At MassBio,... ... [...]
Vision 2030 Early-Stage Catalyst: Fueling Innovation in Massachusetts Biotech
-
BCBN Feed: Bruker Announces Formation of New Bruker Spatial Biology Division https://lnkd.in/gTR-n7-3 BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the formation of a new division, Bruker Spatial Biology, offering the most diverse and comprehensive solutions for spatial biology. Bruker Spatial Biology brings together in operational coordination three entities: the two businesses of NanoString Technologies and Canopy Biosciences, along with... ... [...]
Bruker Announces Formation of New Bruker Spatial Biology Division
